Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

Published 2020 View Full Article

Title

Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

Authors

Keywords

Albumin-bound paclitaxel, Ewing sarcoma, Neuroblastoma, Paediatric, Rhabdomyosarcoma, Solid tumour

Journal

EUROPEAN JOURNAL OF CANCER

Volume 135, Issue -, Pages 89-97

Publisher

Elsevier BV

Online

2020-06-16

DOI

10.1016/j.ejca.2020.04.031

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

© Peeref 2019-2024. All rights reserved.